{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:45:03Z","timestamp":1787427903813,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011833","name":"Guangxi University of Chinese Medicine","doi-asserted-by":"publisher","award":["2024TD001"],"award-info":[{"award-number":["2024TD001"]}],"id":[{"id":"10.13039\/501100011833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011833","name":"Guangxi University of Chinese Medicine","doi-asserted-by":"publisher","award":["GXHC-MBTCM-08"],"award-info":[{"award-number":["GXHC-MBTCM-08"]}],"id":[{"id":"10.13039\/501100011833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2024GXNSFAA010078"],"award-info":[{"award-number":["2024GXNSFAA010078"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8246150205"],"award-info":[{"award-number":["8246150205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jchromb.2025.124784","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T15:36:42Z","timestamp":1756741002000},"page":"124784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Quyu Huazhuo Decoction alleviates non-Alcoholic steatohepatitis via remodeling the gut microbiota and regulating bile acid and short-chain fatty acid metabolism"],"prefix":"10.1016","volume":"1267","author":[{"given":"Lu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongna","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaobin","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jchromb.2025.124784_bb0005","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1111\/liv.16075","article-title":"Clinical outcomes of MAFLD versus NAFLD: a meta-analysis of observational studies","volume":"44","author":"Pennisi","year":"2024","journal-title":"Liver Int."},{"issue":"8","key":"10.1016\/j.jchromb.2025.124784_bb0010","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/cells8080845","article-title":"Current status in testing for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)","volume":"8","author":"Drescher","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.jchromb.2025.124784_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167102","article-title":"Dynamics of cellular plasticity in non-alcoholic steatohepatitis (NASH)","volume":"1870","author":"Rajak","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jchromb.2025.124784_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111648","article-title":"Epidemiology of NAFLD - focus on diabetes","volume":"210","author":"Younossi","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.jchromb.2025.124784_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jchromb.2025.124784_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.jchromb.2025.124784_bb0040","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jchromb.2025.124784_bb0045","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jchromb.2025.124784_bb0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.jchromb.2025.124784_bb0055","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jchromb.2025.124784_bb0060","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.3390\/ijms24032844","article-title":"Advances in the diagnosis and treatment of non-alcoholic fatty liver disease","volume":"24","author":"Yin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2025.124784_bb0065","doi-asserted-by":"crossref","first-page":"1087260","DOI":"10.3389\/fendo.2022.1087260","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.jchromb.2025.124784_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0075","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/j.2040-4603.2022.tb00205.x","article-title":"Bile acids, gut microbiome and the road to fatty liver disease","volume":"12","author":"Hylemon","year":"2021","journal-title":"Compr. Physiol."},{"issue":"Pt 2","key":"10.1016\/j.jchromb.2025.124784_bb0080","article-title":"Effects of traditional Chinese medicine polysaccharides on chronic diseases by modulating gut microbiota: a review","volume":"282","author":"Li","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"04","key":"10.1016\/j.jchromb.2025.124784_bb0085","first-page":"19","article-title":"Study on the mechanism of Bupleurum in preventing and treating non-alcoholic fatty liver disease based on systems pharmacology","volume":"59","author":"Yamei","year":"2024","journal-title":"J. Gansu Agric. Univ."},{"issue":"21","key":"10.1016\/j.jchromb.2025.124784_bb0090","first-page":"5243","article-title":"Network analysis and experimental validation of tanshinone IIA in the treatment of non-alcoholic fatty liver disease","volume":"44","author":"Jianheng","year":"2024","journal-title":"Chinese J. Gerontol."},{"key":"10.1016\/j.jchromb.2025.124784_bb0095","series-title":"Chinese Association of Animal Science and Veterinary Medicine. Innovation, Integration, Health, and Future\u2014Proceedings of the 9th National Conference of Young Veterinary Scholars","first-page":"347","article-title":"Therapeutic effect of Sargassum on rat models of non-alcoholic fatty liver disease","author":"Hao","year":"2020"},{"key":"10.1016\/j.jchromb.2025.124784_bb0100","first-page":"410","article-title":"Fritillaria thunbergii in the treatment of fatty liver","volume":"06","author":"Wenli","year":"2004","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.jchromb.2025.124784_bb0105","unstructured":"Chang Xiaoyan, Li Zhuangzhuang, Wu Jiashuo, et al. Analysis of triterpenoid components in Alisma decoction extract and their effects against non-alcoholic fatty liver disease. Progr. Mod. Biomed., 2021, 21(01): 1\u20137+12."},{"issue":"12","key":"10.1016\/j.jchromb.2025.124784_bb0110","first-page":"1787","article-title":"Network pharmacology-based analysis of the main active components and potential targets of Hawthorn in the treatment of non-alcoholic fatty liver disease","volume":"26","author":"Daobin","year":"2020","journal-title":"J. Basic Chinese Med."},{"issue":"18","key":"10.1016\/j.jchromb.2025.124784_bb0115","first-page":"4576","article-title":"Silymarin inhibits hepatocyte proliferation in aged rats with non-alcoholic fatty liver disease via the JAK\/STAT signaling pathway","volume":"42","author":"Xin","year":"2022","journal-title":"Chin. J. Gerontol."},{"issue":"01","key":"10.1016\/j.jchromb.2025.124784_bb0120","first-page":"6","article-title":"Effect of Cassia seed anthraquinone glycosides on the protein expression of fatty acid \u03b2-oxidation-related enzymes in rats with non-alcoholic fatty liver disease","volume":"34","author":"Yujing","year":"2021","journal-title":"Western J. Trad. Chinese Med."},{"issue":"5","key":"10.1016\/j.jchromb.2025.124784_bb0125","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","article-title":"The microbiota-gut-brain Axis: from motility to mood","volume":"160","author":"Margolis","year":"2021","journal-title":"Gastroenterology"},{"issue":"04","key":"10.1016\/j.jchromb.2025.124784_bb0130","first-page":"3","article-title":"The effect of Quyu Huazhuo granules on insulin resistance in non-alcoholic fatty liver disease","volume":"13","author":"Huang","year":"2013","journal-title":"Practical Clin. J. Integr. Tradit. Chin. West Med."},{"issue":"02","key":"10.1016\/j.jchromb.2025.124784_bb0135","first-page":"44","article-title":"Clinical observation of Quyu Huazhuo decoction in the treatment of nonalcoholic fatty liver with abnormal liver function","volume":"43","author":"Huang","year":"2011","journal-title":"J. New. Chin. Med."},{"key":"10.1016\/j.jchromb.2025.124784_bb0140","unstructured":"Huang H, Huang J, Mao D, et al. Effects of Quyu Huazhuo formula on lipid metabolism and liver function in rats with nonalcoholic fatty liver. Mod. J. Integr. Tradit. Chin. West Med. 2018;27(04):351\u2013353+426 (In Chinese)."},{"issue":"01","key":"10.1016\/j.jchromb.2025.124784_bb0145","first-page":"109","article-title":"Intervention effect of Zhigan formula on the mechanism of selective autophagy of hepatocytes in nonalcoholic steatohepatitis","volume":"34","author":"Li","year":"2019","journal-title":"Chin. J. Tradit. Chin. Med. Pharm."},{"key":"10.1016\/j.jchromb.2025.124784_bb0150","article-title":"Liver steatosis linked to type 2 diabetes outcomes","volume":"384","author":"Bhala","year":"2024","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.jchromb.2025.124784_bb0155","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jama.2024.0799","article-title":"Predicting liver-related outcomes in Steatotic liver disease","volume":"331","author":"Younossi","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jchromb.2025.124784_bb0160","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmet.2024.03.016","article-title":"Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation","volume":"36","author":"Leeson-Payne","year":"2024","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.jchromb.2025.124784_bb0165","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.7150\/thno.93919","article-title":"Unleashing the potential of adipose organoids: a revolutionary approach to combat obesity-related metabolic diseases","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.jchromb.2025.124784_bb0170","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12934-024-02456-4","article-title":"Volatile communication in Actinobacteria: a language for secondary metabolism regulation","volume":"23","author":"Cuervo","year":"2024","journal-title":"Microb. Cell Fact."},{"issue":"2","key":"10.1016\/j.jchromb.2025.124784_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02943-23","article-title":"Gut microbiota dysbiosis and decreased levels of acetic and propionic acid participate in glucocorticoid-induced glycolipid metabolism disorder","volume":"15","author":"Zhang","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.jchromb.2025.124784_bb0185","doi-asserted-by":"crossref","first-page":"1289571","DOI":"10.3389\/fendo.2023.1289571","article-title":"Gut microbiota and metabolites exhibit different profiles after very-low-caloric restriction in patients with type 2 diabetes","volume":"14","author":"Gong","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"5","key":"10.1016\/j.jchromb.2025.124784_bb0190","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00394-022-02839-6","article-title":"Profiles of gut microbiota in obese-insulin-resistant rats treated with biotics","volume":"61","author":"Sriwichaiin","year":"2022","journal-title":"Eur. J. Nutr."},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0195","doi-asserted-by":"crossref","first-page":"L116","DOI":"10.1152\/ajplung.00008.2021","article-title":"Diet-induced obesity in mice impairs host defense against Klebsiella pneumonia in vivo and glucose transport and bactericidal functions in neutrophils in vitro","volume":"322","author":"Mancuso","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"3","key":"10.1016\/j.jchromb.2025.124784_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112003","article-title":"Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD [published correction appears in]","volume":"28","author":"Purohit","year":"2025","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.jchromb.2025.124784_bb0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2017.1406584","article-title":"Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women","volume":"9","author":"Gomez-Arango","year":"2018","journal-title":"Gut Microbes"},{"issue":"20","key":"10.1016\/j.jchromb.2025.124784_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900487","article-title":"A network involving gut microbiota, circulating bile acids, and hepatic metabolism genes that protects against non-alcoholic fatty liver disease","volume":"63","author":"Petrov","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"issue":"6","key":"10.1016\/j.jchromb.2025.124784_bb0215","doi-asserted-by":"crossref","first-page":"G639","DOI":"10.1152\/ajpgi.00226.2021","article-title":"Yeast \u03b2-glucan reduces obesity-associated Bilophila abundance and modulates bile acid metabolism in healthy and high-fat diet mouse models","volume":"321","author":"So","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.jchromb.2025.124784_bb0220","doi-asserted-by":"crossref","first-page":"G399","DOI":"10.1152\/ajpgi.00317.2024","article-title":"Combination of dietary fiber and exercise training improves fat loss in mice but does not ameliorate MASLD more than exercise alone","volume":"328","author":"Kovynev","year":"2025","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.jchromb.2025.124784_bb0225","first-page":"1619","article-title":"Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: evidence from the Henan rural cohort","volume":"34","author":"Yang","year":"2024","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0230","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1038\/s41467-025-58500-3","article-title":"The carotenoid torularhodin alleviates NAFLD by promoting Akkermanisa muniniphila-mediated adenosylcobalamin metabolism","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0235","doi-asserted-by":"crossref","first-page":"22385","DOI":"10.1038\/s41598-024-72909-8","article-title":"Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression","volume":"14","author":"Yang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2025.124784_bb0240","doi-asserted-by":"crossref","first-page":"1447878","DOI":"10.3389\/fnut.2024.1447878","article-title":"Regulation of bile acids and their receptor FXR in metabolic diseases","volume":"11","author":"Li","year":"2024","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0245","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3350\/cmh.2024.0782","article-title":"Bioactive metabolites: a clue to the link between MASLD and CKD?","volume":"31","author":"Chen","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"5","key":"10.1016\/j.jchromb.2025.124784_bb0250","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/nu15051255","article-title":"Gamma-muricholic acid inhibits nonalcoholic steatohepatitis: abolishment of steatosis-dependent peroxidative impairment by FXR\/SHP\/LXR\u03b1\/FASN signaling","volume":"15","author":"Xie","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.jchromb.2025.124784_bb0255","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bph.14095","article-title":"Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124784_bb0260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-230X-13-140","article-title":"The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review","volume":"13","author":"Xiang","year":"2013","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0265","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-023-41061-8","article-title":"Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPAR\u03b1 nucleus-cytoplasm shuttling","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.jchromb.2025.124784_bb0270","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3390\/cells11152337","article-title":"Versatile triad Alliance: bile acid, taurine and microbiota","volume":"11","author":"Duszka","year":"2022","journal-title":"Cells"},{"issue":"10215","key":"10.1016\/j.jchromb.2025.124784_bb0275","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(19)32963-0","article-title":"Obeticholic acid: towards first approval for NASH","volume":"394","author":"Eslam","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jchromb.2025.124784_bb0280","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: another leap forward","volume":"18","author":"Abdelmalek","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10247","key":"10.1016\/j.jchromb.2025.124784_bb0285","first-page":"312","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial [published correction appears in]","volume":"396","author":"Younossi","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jchromb.2025.124784_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202200597","article-title":"Butyrate attenuates hepatic steatosis induced by a high-fat and fiber-deficient diet via the hepatic GPR41\/43-CaMKII\/HDAC1-CREB pathway","volume":"67","author":"Zheng","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.jchromb.2025.124784_bb0295","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcmgh.2021.05.006","article-title":"Sodium butyrate supplementation inhibits hepatic steatosis by stimulating liver kinase B1 and insulin-induced gene","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.jchromb.2025.124784_bb0300","doi-asserted-by":"crossref","first-page":"873","DOI":"10.21037\/atm-21-2158","article-title":"Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"11","key":"10.1016\/j.jchromb.2025.124784_bb0305","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/jgh.15025","article-title":"Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a toll-like receptor 4\/NF-\u03baB signaling pathway","volume":"35","author":"Wu","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jchromb.2025.124784_bb0310","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.jchromb.2025.124784_bb0315","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10096-017-3143-0","article-title":"Gut microbiome production of short-chain fatty acids and obesity in children","volume":"37","author":"Murugesan","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225003381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225003381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:08:30Z","timestamp":1781212110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023225003381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":63,"alternative-id":["S1570023225003381"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124784","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quyu Huazhuo Decoction alleviates non-Alcoholic steatohepatitis via remodeling the gut microbiota and regulating bile acid and short-chain fatty acid metabolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124784"}}